New period product offers progress in women's health
Bryan Hsu is tackling an area of research that has long been neglected—menstrual products.
Jul 10, 2024
0
139
Pathological Conditions, Signs and Symptoms: News and Research on Systemic Inflammatory Response Syndrome
MeSH tree: C23.550.835.900
CAR T cell therapy for advanced prostate cancer demonstrates positive results in Phase I clinical trial
Treating prostate cancer with immunotherapy is currently difficult to do. But results from a first in-human Phase I trial using a chimeric antigen receptor (CAR) T cell therapy developed by researchers from City of Hope, ...
Jun 12, 2024
0
47
Sepsis: Why this deadly condition is so hard to diagnose
Tory MP Craig Mackinlay recently returned to Commons for the first time after suffering from a life-threatening bout of sepsis last year. Since his return to public duties, Mackinlay has spoken candidly about his experience ...
Jun 4, 2024
0
28
White blood cell 'nets' could be early warning sign of major immunotherapy complication
A new study from the University of Michigan Health Rogel Cancer Center reveals a connection between the most common type of white blood cells, which act as a first defense in the body's immune system, and a severe complication ...
Jun 3, 2024
0
26
FDA approves new drug for deadly lung cancer
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer.
May 17, 2024
0
42
Tumor tissue on a chip: New possibilities for cell therapies and personalized medicine
How do tumors react to a certain therapeutic approach? Knowing this before the start of a therapy would be of enormous value for people suffering from cancer as well as for the doctors treating them.
May 15, 2024
0
44
Study shows how sepsis can affect vascular smooth muscle cells on an acute and long-term basis
A recent study by University Medicine Halle shows how sepsis can lead to dysfunction of vascular smooth muscle cells. The researchers found that elevated lactate levels and acidosis, which can occur acutely during sepsis ...
May 8, 2024
0
32
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial
Researchers at Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist have published results of a Phase I clinical trial of a ...
Apr 24, 2024
0
54
FDA approves Abecma for relapsed, refractory multiple myeloma
The U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.
Apr 10, 2024
0
35
Sepsis signature shifts speed of diagnosis
Sepsis and septic shock patients could experience faster diagnosis and better outcomes thanks to new Western Australian research.
Apr 10, 2024
0
46
